tiprankstipranks
Trending News
More News >
BML Inc (JP:4694)
:4694

BML (4694) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4694

BML

(4694)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
,
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
¥4,516.00
▲(18.37% Upside)
Action:ReiteratedDate:11/01/25
BML's strong financial performance and positive technical indicators are the primary drivers of its stock score. The company's robust balance sheet and profitability metrics provide a solid foundation, while technical analysis suggests a positive market trend. The valuation is reasonable, with a moderate P/E ratio and attractive dividend yield. However, declining revenue and fluctuating cash flow present potential risks.
Positive Factors
Balance sheet strength
A strong equity base and low leverage reduce bankruptcy risk and preserve financial flexibility. This durability supports sustained investment, dividend capacity, and resilience to industry downturns, enabling multi‑quarter strategic planning and capital deployment without reliance on volatile financing.
Sustained profitability margins
Consistent gross and net margins indicate structural cost advantages and pricing power in diagnostic services. Margin durability drives steady operating cash conversion, funds R&D and equipment renewal, and cushions against volume softness, supporting multi‑period profitability even if top-line growth slows.
Operating cash flow generation
Reliable operating cash flow demonstrates the company's ability to fund working capital, capex and shareholder returns from operations. Even with FCF volatility, steady operating cash generation underpins financial stability and reduces dependency on external funding for medium‑term strategic initiatives.
Negative Factors
Recent revenue decline
A persistent revenue decline undermines long‑term growth prospects and puts pressure on fixed‑cost absorption. Without reversing top‑line trends, profitability and investment plans may rely more on cost cuts than expansion, limiting sustainable earnings growth and strategic optionality over the next several quarters.
Free cash flow volatility
Significant FCF swings create uncertainty for capital allocation, dividend reliability and funding of strategic projects. Volatility complicates multi‑period planning, may force opportunistic financing in weak periods, and raises execution risk for investments that require predictable internal funding.
Erosion of operating margins
Shrinking EBIT/EBITDA margins suggest rising costs or pricing pressure that could persist absent structural fixes. Margin erosion reduces free cash generation and limits reinvestment potential, making long‑term profitability more sensitive to revenue fluctuations and competitive intensity in diagnostics.

BML (4694) vs. iShares MSCI Japan ETF (EWJ)

BML Business Overview & Revenue Model

Company DescriptionBML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
How the Company Makes Moneynull

BML Financial Statement Overview

Summary
BML exhibits strong profitability indicators with a consistent gross profit margin and a healthy net profit margin. The company maintains a robust balance sheet with a strong equity base and low debt-to-equity ratio, indicating financial stability. However, declining revenue and fluctuating free cash flow could pose future challenges.
Income Statement
78
Positive
BML exhibits strong profitability indicators with a consistent gross profit margin and a healthy net profit margin, reflecting effective cost management and strong revenue generation. However, the company has experienced a decline in revenue over recent years, which could be a concern for future growth. The EBIT and EBITDA margins indicate efficient operations, although they have decreased from prior years, suggesting room for improving operational efficiency.
Balance Sheet
85
Very Positive
BML maintains a robust balance sheet with a strong equity base and a low debt-to-equity ratio, indicating financial stability and a low risk of financial distress. The equity ratio suggests strong capitalization, providing a solid buffer against liabilities. The return on equity has remained healthy, showcasing efficient use of shareholders' funds despite a decrease in net income in recent periods.
Cash Flow
70
Positive
BML's cash flow management appears stable, with positive operating cash flow supporting its operations. However, free cash flow has fluctuated significantly, pointing to potential volatility in capital expenditures and investment activities. The operating cash flow to net income ratio demonstrates the company's ability to convert income into cash, although the volatility in free cash flow indicates potential challenges in maintaining consistent cash generation.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue145.63B143.19B137.96B159.46B186.07B138.57B
Gross Profit46.42B45.86B45.63B61.45B86.95B54.77B
EBITDA17.84B17.08B15.96B30.29B54.78B25.39B
Net Income6.42B6.26B6.04B15.58B33.74B13.71B
Balance Sheet
Total Assets175.54B177.99B171.46B169.27B179.59B139.17B
Cash, Cash Equivalents and Short-Term Investments65.46B67.56B74.11B86.52B92.13B63.48B
Total Debt4.29B5.29B5.26B4.16B3.35B3.29B
Total Liabilities42.81B44.21B41.32B42.52B57.91B46.05B
Stockholders Equity128.46B129.40B125.87B122.49B116.20B88.42B
Cash Flow
Free Cash Flow0.00663.00M-4.57B7.18B39.91B16.48B
Operating Cash Flow0.0015.81B14.45B11.74B45.60B19.57B
Investing Cash Flow0.00-16.79B-21.14B-7.63B-7.30B-4.58B
Financing Cash Flow0.00-5.43B-5.73B-9.71B-9.83B-3.38B

BML Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3815.00
Price Trends
50DMA
4020.50
Positive
100DMA
3899.15
Positive
200DMA
3667.59
Positive
Market Momentum
MACD
-5.44
Positive
RSI
46.59
Neutral
STOCH
36.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4694, the sentiment is Positive. The current price of 3815 is below the 20-day moving average (MA) of 4129.25, below the 50-day MA of 4020.50, and above the 200-day MA of 3667.59, indicating a neutral trend. The MACD of -5.44 indicates Positive momentum. The RSI at 46.59 is Neutral, neither overbought nor oversold. The STOCH value of 36.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4694.

BML Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥150.71B15.475.94%3.34%5.90%16.30%
74
Outperform
¥62.61B14.392.79%28.06%19.48%
68
Neutral
¥93.50B26.702.31%4.36%79.43%
52
Neutral
¥138.12B-8.842.18%-0.16%-802.20%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥126.72B28.052.42%3.73%0.04%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4694
BML
4,030.00
1,120.40
38.51%
JP:6523
PHC Holdings Corp.
1,000.00
-15.80
-1.56%
JP:2395
Shin Nippon Biomedical Laboratories, Ltd.
1,504.00
34.09
2.32%
JP:4549
Eiken Chemical Co., Ltd.
2,836.00
608.63
27.33%
JP:4974
Takara Bio Inc.
1,147.00
317.59
38.29%

BML Corporate Events

BML Revises First-Quarter 2024 Earnings Data After Discovering Numerical Errors
Mar 16, 2026

BML, Inc. has announced corrections to its consolidated earnings report for the first quarter of fiscal 2024 under Japanese GAAP, after discovering errors in previously disclosed numerical data. The revisions mainly affect the company’s reported total assets and equity ratio as of June 30, 2024, and March 31, 2024, while net assets and equity capital figures remain unchanged.

Following the corrections, total assets at the end of the first quarter are now reported as ¥176,267 million, compared with ¥176,384 million at the end of the previous fiscal year, reflecting a modest decline. The equity ratio has been adjusted downward to 71.4% from the previously reported 73.7%, indicating a slightly lower capital adequacy than initially disclosed, though the impact on BML’s overall financial position appears limited.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Corrects Third-Quarter 2024 Balance Sheet Figures and Equity Ratio
Mar 16, 2026

BML, Inc., a Japan-based clinical testing and diagnostic services provider listed on the Tokyo Prime Market, has issued a correction to its previously disclosed consolidated earnings report for the third quarter of fiscal 2024. The revision updates key balance sheet figures, including total assets and the equity ratio, while net assets and equity capital remain unchanged.

The company now reports total assets of ¥179,251 million as of December 31, 2024, up ¥2,866 million from the previous fiscal year-end, compared with the earlier, lower figure of ¥173,867 million. The corrected equity ratio is 71.2%, indicating a larger asset base but slightly lower capital efficiency than initially stated, a technical adjustment that clarifies BML’s financial position for investors without materially altering its net asset levels.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Corrects Fiscal 2024 Earnings Report, Adjusts Asset and Profitability Ratios
Mar 16, 2026

BML, Inc. has announced corrections to its previously released consolidated earnings report for fiscal 2024, identifying and amending errors discovered after the original disclosure in May 2025. The revisions affect key profitability and balance sheet indicators but leave per-share earnings figures unchanged.

The company slightly adjusted its reported ordinary profit-to-total-assets ratios for fiscal 2024 and 2023, signaling a modest recalibration of capital efficiency metrics rather than a change in underlying earnings. It also restated total assets and equity ratios for March 31, 2025 and March 31, 2024, reflecting higher total assets and lower equity ratios, which may influence investor assessments of leverage and financial stability without altering reported net assets or net assets per share.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Revises First-Quarter FY2025 Balance-Sheet Figures, Lowers Reported Equity Ratio
Mar 16, 2026

BML, Inc. has corrected previously disclosed figures in its consolidated earnings report for the first quarter of fiscal 2025, released on August 8, 2025, after identifying errors in its financial position data. The revisions primarily affect reported total assets and the equity ratio as of June 30 and March 31, 2025.

Under the corrected data, total assets at June 30, 2025 are now stated as ¥180,917 million instead of ¥175,537 million, while total assets at March 31, 2025 are revised to ¥182,873 million from ¥177,507 million. Correspondingly, the equity ratio has been adjusted downward to 71.0% from 73.2% at June 30 and to 70.7% from 72.9% at March 31.

Despite these asset and ratio revisions, net assets remain unchanged at ¥132,724 million at June 30, 2025 and ¥133,772 million at March 31, 2025, indicating the corrections primarily reclassify or restate asset values rather than altering shareholders’ equity. The company also made a minor adjustment in the decline of investments and other assets, now reported as a ¥432 million decrease instead of ¥446 million.

Operationally, BML notes that cash and deposits fell by ¥2,101 million while trade receivables increased by ¥1,288 million, property, plant and equipment declined by ¥523 million, and current liabilities decreased by ¥1,041 million, with retained earnings down ¥867 million. Overall, the corrected disclosure refines the company’s balance-sheet presentation and slightly weakens its reported equity ratio, but does not materially change the narrative of a modest contraction in its asset base over the period.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Revises First-Half Fiscal 2025 Balance Sheet Figures After Data Errors
Mar 16, 2026

BML, Inc. announced it has corrected errors in its previously released consolidated earnings report for the first six months of fiscal 2025, adjusting key balance sheet figures while keeping equity capital unchanged. The revised data show total assets of ¥179,164 million as of September 30, 2025, and ¥182,873 million as of March 31, 2025, lowering the reported equity ratio to 70.1% and 70.7%, respectively, though net assets and the magnitude of their decline versus the prior fiscal year remain the same.

The company clarified that the updated figures mean total assets decreased by ¥3,708 million over the end of the previous fiscal year, slightly more than initially reported, while net assets still fell by ¥3,761 million. Despite the corrections, the equity ratio decline is unchanged at 0.6 percentage points, indicating that while BML’s reported financial position is modestly weaker than first disclosed, the overall trajectory of its capital structure and balance-sheet health remains consistent for investors and other stakeholders.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Revises Third-Quarter Fiscal 2025 Balance Sheet Figures
Mar 16, 2026

BML, Inc. has corrected previously disclosed figures in its consolidated earnings report for the third quarter of fiscal 2025, revising total assets upward while leaving net assets unchanged. The company reported that total assets as of December 31, 2025 were ¥182,201 million instead of ¥176,860 million, reducing the equity ratio from 71.1% to 69.0%.

The revised data also adjust the comparison with the prior fiscal year-end, now showing a ¥671 million decrease in total assets from March 31, 2025 instead of ¥646 million, while the decline in net assets remains ¥3,642 million. These corrections slightly worsen BML’s reported capital structure metrics, which may refine investors’ view of its balance sheet strength but do not alter the underlying net asset trend disclosed in the original report.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Restates Five Years of Filings Over Retirement Benefit Accounting Error
Mar 16, 2026

BML, Inc. has submitted correction reports for past annual, semi-annual and quarterly securities filings, along with related earnings reports, after discovering errors in the accounting treatment of retirement benefit assets and liabilities. The company determined, in consultation with its audit firm, that it had improperly offset funded retirement benefit assets against obligations and will now apply the correct method retroactively, though it reported no impact on income statements for the affected periods.

The restatements cover the past five fiscal years of annual securities reports and earnings releases, as well as three years of interim and quarterly filings, indicating a broad technical adjustment rather than a change in business performance. While the corrections are not expected to alter reported profits, they may prompt closer investor scrutiny of BML’s internal controls and financial reporting processes, as the company seeks to reassure stakeholders by proactively revising its disclosures.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4260.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Raises Full-Year Earnings Forecast on New Customer Growth and Price Optimization
Feb 6, 2026

BML, Inc. has revised upward its consolidated earnings forecast for the fiscal year ending March 31, 2026, citing stronger-than-expected performance. The company now projects net sales of ¥149.0 billion, operating profit of ¥10.0 billion, ordinary profit of ¥10.5 billion, and profit attributable to owners of parent of ¥7.0 billion, all above the previous forecast and surpassing last year’s results, with basic earnings per share expected to rise to ¥183.88. Management attributes the improved outlook to steady acquisition of new customers and successful price optimization initiatives started in the prior fiscal year, which more than offset increased depreciation costs linked to new wings at the BML General Laboratory, signaling stronger profitability and operational leverage despite higher investment-related expenses.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4233.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Delivers Strong Q3 Earnings and Raises Full-Year Outlook While Maintaining Dividend Plan
Feb 6, 2026

BML reported solid growth for the third quarter of fiscal 2025, with net sales rising 5.4% year-on-year to ¥114.5 billion and profit attributable to owners of the parent climbing 24.6% to ¥6.6 billion, reflecting improved profitability and higher earnings per share. Despite a slight decline in total assets and equity ratio compared with the end of the previous fiscal year, the company maintained a robust financial position and confirmed its full-year dividend forecast of ¥120 per share, while revising its full-year earnings outlook upward to project increases in sales, operating profit and net income, signaling continued earnings momentum and shareholder returns stability.

The most recent analyst rating on (JP:4694) stock is a Hold with a Yen4233.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

BML Overhauls Shareholder Benefits to Reward Long-Term Investors
Jan 26, 2026

BML, Inc. has approved changes to its shareholder benefits program aimed at expressing gratitude to investors while making its shares more attractive for long-term ownership. Effective for shareholders of record as of March 31, 2027, the company will scrap its previous, no-holding-period structure—where investors with at least 100 shares received QUO cards worth ¥1,500 or ¥3,000 depending on stake size—and replace it with a tenure-based system. Under the revised program, only shareholders holding 100 shares or more for at least one year will receive a QUO card worth ¥3,000, increasing to ¥5,000 for those with a holding period of three years or more, as verified through continuous appearance in the shareholder registry on semiannual record dates. The move aligns BML’s incentives more clearly with shareholder loyalty and is likely to support a more stable shareholder base by rewarding extended holding periods rather than short-term ownership.

The most recent analyst rating on (JP:4694) stock is a Buy with a Yen4095.00 price target. To see the full list of analyst forecasts on BML stock, see the JP:4694 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025